Summary Desktop Genetics Ltd (DeskGen) is a provider of genome editing solutions.The company offers software solutions for the design, synthesis and assembly of DNA.
It offers deskgen, which is a software system that helps scientists to organize, optimize, and automate their research.DeskGen’s CRISPR/Cas9 technology allows the engineering of animal, plant, and microbial cell genomes.
The company’s autoclone is an automated DNA research engine that offers design, synthesis, management, and sharing of DNA constructs.It serves biotechnology companies and genome engineering companies across the UK.
DeskGen is headquartered in London, the UK.
Desktop Genetics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
2019 Animal Health Pharmaceuticals, Feed Additives, Biologicals, Diagnostics: Market Segment and Geographic Region Forecasts, Trends and Outlook The report provides a strategic overview of the worldwide animal health market, including:• Five-year forecasts for:- Major market segments.- Key...
236 pages •
By Global Industry Analysts
• May 2019
This report analyzes the worldwide markets for DNA Probes-Based Diagnostics in US$ Million by the following Application Areas: Infectious Diseases, Cancer Testing, Genetic Predisposition, Identity/Forensics, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific,...
The Global Molecular Diagnostics Partnering 2014-2019 report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details...
463 pages •
By Global Industry Analysts
• May 2019
This report analyzes the worldwide markets for Biotechnology Instrumentation in US$ Thousand by the following Product Segments: DNA Sequencing Systems, DNA Synthesizers, Electrophoresis Systems, Immunoassay Systems, Laboratory Automation, Liquid Chromatography Systems, Mass Spectrometry, MicroArrays, and Protein/Peptide Synthesizers. The...
The Asia Pacific genomics market is expected to reach US$ 7.6 Bn in 2025 from US$ 3.2 Bn in 2017. The market is estimated to grow with a CAGR of 10.6% from 2018-2025. The growth of the genomics market is primarily attributed to the increasing number of start-up companies and medical genetics in developing countries.However, nonexistence...
The Europe genomics market is expected to reach US$ 10.1 Bn in 2025 from US$ 4.6 Bn in 2017. The market is estimated to grow with a CAGR of 10.6% from 2018-2025. The growth of the genomics market is primarily attributed to the rise in the advancements for genome editing technologies and technological developments in genomics.However, nonexistence...
The North America genomics market is expected to reach US$ 13.3 Bn in 2025 from US$ 5.9 Bn in 2017. The market is estimated to grow with a CAGR of 11.0% from 2018-2025. The growth of the genomics market is primarily attributed to the growth in investments & funds for genomics and declining cost of sequencing procedures.However, high cost...
2019 Molecular Diagnostics Market: Supplier Shares by Product and Country, Emerging Technologies, Strategic Profiles of Leading Suppliers This 185-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA...
The Global Genomics Partnering Terms and Agreements 2014 to 2019 report provides an understanding and access to the Genomics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Genomics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage...
The North America next generation sequencing market is expected to reach US$ 10,733.0 Mn in 2025 from US$ 2,378.5 Mn in 2017. The market is estimated to grow with a CAGR of 20.7% from 2018-2025. The growth of the next generation sequencing market is primarily attributed to the declining price of sequencing and increasing prevalence of cancer.However,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.